Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Inflammatory Bowel Diseases|September 22, 2018
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter ObservationDana Duricova, Eva Dvorakova, Ondrej Hradsky, et al.Pediatric Research|November 27, 2023
Sustainability of biologic treatment in paediatric patients with Crohn's disease: population-based registry analysisOndrej Hradsky, Ivana Copova, Marianna Durilova, et al.Therapeutic Advances in Gastroenterology|August 16, 2021
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre studyKatarina Mitrova, Barbora Pipek, Martin Bortlik, et al.World Journal of Gastroenterology|November 5, 2010
NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patientsNora Meggyesi, Lajos S Kiss, Magdalena Koszarska, et al.Journal of Crohn'S & Colitis|June 16, 2022
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre StudyKatarina Mitrova, Barbora Pipek, Martin Bortlik, et al.Journal of Crohn'S & Colitis|June 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY surveyGionata Fiorino, Catarina Fidalgo, Michel Adamina, et al.Journal of Crohn'S & Colitis|April 24, 2016
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative ColitisKlaudia Farkas, Mariann Rutka, Petra A Golovics, et al.Expert Opinion on Biological Therapy|October 3, 2018
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohortAnita Bálint, Mariann Rutka, Martin Kolar, et al.Journal of Crohn'S & Colitis|June 13, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY surveyGionata Fiorino, Alissa Walsh, Michel Adamina, et al.Expert Opinion on Drug Safety|May 16, 2017
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohortAnita Bálint, Mariann Rutka, Zsuzsanna Végh, et al.Pageof 4